115 related articles for article (PubMed ID: 7043954)
21. [The correlation of in vivo and in vitro effect of cytostatics in transplantated tumours of the mouse (author's transl)].
Hecker D; Rose H; Powitz A
Acta Histochem; 1978; 62(1):95-109. PubMed ID: 99968
[TBL] [Abstract][Full Text] [Related]
22. [Estimation of the uric acid concentration in the blood-serum during cytostatic therapy of ovarian cancer (author's transl)].
Kudela M; Podivínský R
Cesk Gynekol; 1979 May; 44(4):282-4. PubMed ID: 445608
[No Abstract] [Full Text] [Related]
23. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma.
Andreotti PE; Cree IA; Kurbacher CM; Hartmann DM; Linder D; Harel G; Gleiberman I; Caruso PA; Ricks SH; Untch M
Cancer Res; 1995 Nov; 55(22):5276-82. PubMed ID: 7585588
[TBL] [Abstract][Full Text] [Related]
24. [Cytogenetic studies for detection of tumour strain lines of ovarian cancer cells (author's transl)].
Kademann R; Marx B; Krafft W; Kademann J; Preibsch W; Behling H; Brückmann D
Zentralbl Gynakol; 1981; 103(3):176-80. PubMed ID: 7234217
[TBL] [Abstract][Full Text] [Related]
25. [Tactics of the cytostatic treatment in ovarian cancers (author's transl)].
Budinská B
Cesk Gynekol; 1976 Dec; 41(10):722-3. PubMed ID: 1009603
[No Abstract] [Full Text] [Related]
26. Correlation of drug response with the ATP tumorchemosensitivity assay in primary FIGO stage III ovarian cancer.
Konecny G; Crohns C; Pegram M; Felber M; Lude S; Kurbacher C; Cree IA; Hepp H; Untch M
Gynecol Oncol; 2000 May; 77(2):258-63. PubMed ID: 10785475
[TBL] [Abstract][Full Text] [Related]
27. Effect of culture conditions on the chemosensitivity of ovarian cancer cell lines.
Fernando A; Glaysher S; Conroy M; Pekalski M; Smith J; Knight LA; Di Nicolantonio F; Cree IA
Anticancer Drugs; 2006 Sep; 17(8):913-9. PubMed ID: 16940801
[TBL] [Abstract][Full Text] [Related]
28. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
29. Medical therapy of advanced malignant epithelial tumours of the ovary.
Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
[TBL] [Abstract][Full Text] [Related]
30. [Growth of tumour-cell colonies from human solid tumours (author's transl)].
Schlag P; Wolfrum J; Vergani G; Schreml W; Herfarth C
Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1173-7. PubMed ID: 6179731
[TBL] [Abstract][Full Text] [Related]
31. [Results obtained with directed chemotherapy of ovarian cancer (author's transl)].
Dvorák O
Cesk Gynekol; 1976 Dec; 41(10):717-8. PubMed ID: 1009601
[No Abstract] [Full Text] [Related]
32. [Resistance testing and chemotherapy results in animal and human tumors].
Volm M; Mattern J; Wayss K
Verh Dtsch Ges Pathol; 1978; 62():368. PubMed ID: 746886
[No Abstract] [Full Text] [Related]
33. [New developments in the chemotherapy of ovarian cancer (author's transl)].
Brunner KW; Goldhirsch A; Joss R
Schweiz Rundsch Med Prax; 1981 Apr; 70(18):809-14. PubMed ID: 7243721
[No Abstract] [Full Text] [Related]
34. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
Yahata H; Kobayashi H; Kamura T; Amada S; Hirakawa T; Kohno K; Kuwano M; Nakano H
J Cancer Res Clin Oncol; 2002 Nov; 128(11):621-6. PubMed ID: 12458343
[TBL] [Abstract][Full Text] [Related]
35. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.
Nicoletti MI; Valoti G; Giannakakou P; Zhan Z; Kim JH; Lucchini V; Landoni F; Mayo JG; Giavazzi R; Fojo T
Clin Cancer Res; 2001 Sep; 7(9):2912-22. PubMed ID: 11555610
[TBL] [Abstract][Full Text] [Related]
36. Clinical correlations of in vitro drug sensitivity.
Salmon SE; Alberts DS; Meyskens FL; Durie BG; Jones SE; Soehnlen B; Young L; Chen HS; Moon TE
Prog Clin Biol Res; 1980; 48():223-45. PubMed ID: 7193872
[No Abstract] [Full Text] [Related]
37. Use of tissue culture in predictive testing of drug sensitivity in human ovarian cancer. Correlation between in vitro results and the response in vivo.
Tropé C; Sigurdsson K
Neoplasma; 1982; 29(3):309-14. PubMed ID: 7133226
[TBL] [Abstract][Full Text] [Related]
38. [Pretherapeutical testing of antineoplastic drugs in vitro (author's transl)].
Projan A; Tanneberger S; Peek U; Nissen E
Arch Geschwulstforsch; 1982; 52(1):1-7. PubMed ID: 7082128
[TBL] [Abstract][Full Text] [Related]
39. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
Frankel A; Buckman R; Kerbel RS
Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
[TBL] [Abstract][Full Text] [Related]
40. TCA-100 tumour chemosensitivity assay: differences in sensitivity between cultured tumour cell lines and clinical studies.
Andreotti PE; Linder D; Hartmann DM; Cree IA; Pazzagli M; Bruckner HW
J Biolumin Chemilumin; 1994; 9(6):373-8. PubMed ID: 7879653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
